资源描述：
《腹水治疗注意（Attention to ascites therapy）.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、腹水治疗注意(Attentiontoascitestherapy)NutritionandguardianshipForthetreatmentofascites,weshouldnotignorethenutritionaltreatmentoftheoriginalliverdisease.Forthemonitoringofascites,note:1,observethementaistate,suchasflappingwingliketremor;2,dailyweight;3,remembertheamount;4,oftencheckelectrolyte,ureani
2、trogenandmuscleliver;5,repeatedlychecktheoriginalliverdisease・TwobedrestInthecaseofbedrest,accordingtothepatient'sproperactivities・Three・LimitsaltandwaterDailysodiumisnotmorethan500mg(sodiumchloride3.75g),solidlg,sodiumchloridecontainssodium0.4g.Theusualdietwithoutsaltis2-4Gofsodiumchloride,soda
3、ilysaltfreedietisrequired・Suchasimprovedslightlyrelaxed,butstilldailyat11.5g,insomecases,nosaltorsaltrestriction,donotsignificantlyaffectthediet,butinsomecases,lesssaltsignificantlyaffectedbydiet,itisnecessarytorelaxthesaltstandard,notsignificantlyaffectthediet・Generalwaterintakeislimitedto1000一
4、1500ml,suchasbloodsodiumislowerthan130mmol/L,butshouldstrictlylimitwaterintake,lessthan1000mlperday.Afterdiuresis,diuresisisneededtocontroltheamountofwaterneededtoavoidhyponatremia・Thelatterisoneofthesignsofpoorprognosisincirrhosis,andtheprimarytreatmentistolimittheintakeofwater・Inpatientswithci
5、rrhosisascitesorascitestendency,ifintravenousinfusionliquidcanpromotetheoccurrenceofascitesoraggravate,whenstopinfusionordiuretics,suchasascitescanreduceordisappearquickly,calledfortheinfusionofascitessyndrome・Therefore,cirrhosiswithascitespatients,asfaraspossiblenottoinfusion,toinfusionisless,t
6、hebetter・Four,diuretics1,payattentiontowhetheraccompaniedbyedema,ascites,accompaniedbyedema,canbealargenumberofdiuretic,withoutsideeffects・Atthesametime,someedemafluidisexpelled・Butoncetheedemahasdisappearedoronlytheasciteshasnoedema,usediureticstoslowdown,preventlowbloodvolume,electrolytedistur
7、bances,andhypoxemia・Weightreductioncriteria:thereisperipheraledema,dailylkgappropriate,nosurroundingedema,0.5kgperdayisappropriate・2,thechoiceofdrugs1,spironolactone:asthedrugofchoice,andthemostcompetitivealdosteronereceptor
